It belongs to a group of drugs called antipsychotics. Invega Sustenna is a brand-name medication. A generic version of the drug isn’t currently available. Invega Sustenna has a boxed warning.
Cellular’s neuropsychiatric assets is Caplyta, a pill approved for schizophrenia and bipolar depression and proposed for ...
Johnson & Johnson kicked off the J.P. Morgan Healthcare Conference on Monday with the $14.6 billion acquisition of Intra-Cellular Therapies.
Vadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug ...
Hormonal birth control pills can cause mild side effects such as acne, bloating, and spotting. In rare instances, they may increase your risk of more serious health issues, like blood clots.
The best Android tablets can do it all. They pack enough power to run apps and games with minimal or no slowdown. They're also energy-efficient enough to last long on a single charge. And when ...
Whether you're a digital artist, photographer or animator, the best drawing tablets could help to level up your craft. These slates offer a purpose-made canvas for creatives, from students and ...
Tablets are used for a variety of reasons, but they're especially perfect for note taking. These devices are a digital alternative to pen and paper, making it easier than ever for students and ...
Large tablets often feel large and unwieldy, but some manufacturers have taken this into consideration by combining lightweight designs with premium materials and excellent viewing angles.
Any remaining spot of rain will clear early, and the rest of the night will continue with a mixture of variable cloud and clear spells. Not as cold compared to previous nights. Some fog by dawn ...
You don't need to leave your home to reliably get your prescription medications. Here are our top picks of the best services that deliver medicines. Mercey Livingston is a health and wellness ...
Second place was Johnson & Johnson’s schizophrenia treatment Invega Sustenna/Invega Trinza (paliperidone), with a 6.8% increase in the list price – and 10.7% net – which added $203 million ...